Low-Intensity Shock Wave Therapy for Erectile Dysfunction
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial investigates whether low-intensity shock wave therapy (LiSWT) can improve erectile function in men. Researchers aim to determine if this therapy can enhance male sexual health and identify the best treatment plan. Participants will be compared to those receiving standard treatments, such as medications or devices. Men who have experienced erectile dysfunction for at least six months may be suitable for this study. As an unphased trial, this study offers a unique opportunity to contribute to groundbreaking research in male sexual health.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are on anticoagulant or anti-platelet therapy (medications that prevent blood clots).
What prior data suggests that this therapy is safe for erectile dysfunction?
A previous study found low-intensity shock wave therapy (LiSWT) to be a safe treatment for erectile dysfunction. Research shows that most patients tolerate it well, with few reports of serious side effects. Some patients might experience minor discomfort or notice bruising in the treated area, but these usually resolve on their own.
Experts indicate that more long-term studies are needed to fully understand its safety over time. This treatment is already used for some other conditions, suggesting it is quite safe. However, like any treatment, it is important to consider the potential benefits and risks. Always consult a healthcare provider when considering joining a clinical trial.12345Why are researchers excited about this trial?
Low-Intensity Shock Wave Therapy (LiSWT) is unique because it offers a non-invasive approach to treating erectile dysfunction (ED) by using acoustic waves to improve blood flow. Unlike standard treatments like pills, pumps, or injections that provide temporary symptom relief, LiSWT aims to address the root cause by promoting the natural repair of blood vessels. Researchers are excited about this therapy because it has the potential to provide longer-lasting improvements in erectile function without the need for ongoing medication or devices.
What evidence suggests that low-intensity shock wave therapy is effective for erectile dysfunction?
This trial will compare low-intensity shock wave therapy (LiSWT) with standard treatments for erectile dysfunction (ED). Studies have shown that LiSWT can improve erectile function in men with ED. Research suggests that LiSWT may help by boosting blood flow to the penis, which is crucial for achieving and maintaining an erection. In some studies, men reported better erections after receiving LiSWT compared to those who did not receive the treatment. This therapy is considered promising, with results indicating improvements regardless of ED severity. However, researchers are still determining the optimal use of this treatment, including the number of sessions needed and the strength of the waves, to ensure lasting effects.26789
Who Is on the Research Team?
Danielle Velez Leitner, MD
Principal Investigator
Rutgers Health
Are You a Good Fit for This Trial?
This trial is for men with erectile dysfunction. Participants will be asked to complete questionnaires and those opting for LiSWT will undergo six weekly sessions. Details on inclusion and exclusion criteria are not provided.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive low-intensity shock wave therapy (LiSWT) once per week for 6 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment using validated questionnaires
Long-term follow-up
Participants continue to be monitored for long-term effects and efficacy of the treatment
What Are the Treatments Tested in This Trial?
Interventions
- Low intensity shock wave
Find a Clinic Near You
Who Is Running the Clinical Trial?
Rutgers, The State University of New Jersey
Lead Sponsor